ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M601. A total of 37 filers reported holding ACORDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $747,000 | -32.7% | 464,276 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $1,110,000 | -48.5% | 464,276 | -0.8% | 0.00% | -55.6% |
Q3 2021 | $2,154,000 | -49.2% | 468,166 | -47.3% | 0.01% | -52.6% |
Q2 2021 | $4,240,000 | -2.3% | 888,899 | -0.3% | 0.02% | -5.0% |
Q1 2021 | $4,342,000 | – | 891,626 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CANYON CAPITAL ADVISORS LLC | 392,904 | $1,874,000 | 0.07% |
Saltoro Capital, LP | 11,853 | $57,000 | 0.02% |
Point72 Asset Management, L.P. | 888,899 | $4,240,000 | 0.02% |
United Asset Strategies, Inc. | 27,100 | $129,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,590 | $485,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 379,922 | $1,812,000 | 0.01% |
Virtu Financial LLC | 10,119 | $48,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 135,190 | $645,000 | 0.00% |
Renaissance Technologies | 714,118 | $3,406,000 | 0.00% |
FEDERATED HERMES, INC. | 104,816 | $500,000 | 0.00% |